Working to develop the scientific basis for a permanent regulatory framework for anthroposophic medicinal products in Europe

Evaluation of AM and AMPs as a whole system



  1. Baars EW, Kooreman P. A 6-year comparative economic evaluation of healthcare costs and mortality rates of Dutch patients from conventional and CAM GPs. BMJ Open 2014;4(8):e005332.
  2. Heinz J, Fiori W, Heusser P, Ostermann T. Cost analysis of integrative inpatient treatment based on DRG data: The example of Anthroposophic Medicine. Evid Based Complement Alternat Med 2013.
  3. Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ 2012;13(6):769-76.
  4. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Kienle GS, Willich SN, et al. Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings. Eur J Health Econ 2010;11(1):77-94.
  5. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Health costs in anthroposophic therapy users: a two-year prospective cohort study. BMC Health Serv Res 2006;6(65).